Skip to main content
Dr. Lal Pathlabs Limited logo

Dr. Lal Pathlabs Limited — Investor Relations & Filings

Ticker · LALPATHLAB ISIN · INE600L01024 LEI · 984500E8E9CY102B9718 BSE.NS Human health and social work activities
Open in API
Filings indexed 1,098 across all filing types
Latest filing 2020-02-04 Regulatory Filings
Country IN India
Listing BSE.NS LALPATHLAB

About Dr. Lal Pathlabs Limited

https://www.lalpathlabs.com/

Dr. Lal Pathlabs Limited is a provider of diagnostic and related healthcare tests and services. The company offers a comprehensive range of clinical laboratory tests and profiles used for prediction, early detection, diagnostic screening, confirmation, and monitoring of diseases. Its service portfolio encompasses pathology, including biochemistry, hematology, clinical pathology, histopathology, and molecular diagnostics, as well as radiology services such as X-ray, ultrasound, and CT scans. The organization operates an extensive network of laboratories, patient service centers, and pick-up points, utilizing advanced automated systems and standardized processes. Key offerings include specialized wellness packages and home sample collection. The company maintains high quality standards through international and national accreditations, serving a diverse patient base and healthcare providers with a focus on accuracy and timely reporting.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice dated February 4, 2020, addressed to stock exchanges, informing them about the schedule of analyst/institutional investor meetings. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events. The content is an announcement of upcoming meetings with investors, explicitly stating no unpublished price sensitive information will be shared. The document does not contain any financial data, report, or detailed presentation but is a notification of investor meetings. This fits the category of Investor Presentation announcements or updates. However, since it is only an intimation of the schedule of meetings and not the presentation itself, it is best classified as a Regulatory Filing (RNS) as a general regulatory announcement. The document length is short (1828 characters), and it is an announcement rather than a report or transcript.
2020-02-04 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice dated February 4, 2020, addressed to stock exchanges regarding the schedule of analyst and institutional investor meetings. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure obligations. The content is an announcement of upcoming investor meetings, explicitly stating no unpublished price sensitive information will be shared. The document is brief (1817 characters) and does not contain any financial data, results, or detailed reports. It is not a financial report, earnings release, or management discussion. It is an update on investor relations activities, specifically the schedule of meetings with analysts and institutional investors. This fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories. Therefore, the classification is RNS with high confidence.
2020-02-04 English
Appointment
Regulatory Filings
2020-02-03 English
Appointment
Regulatory Filings
2020-02-03 English
Appointment
Regulatory Filings
2020-02-03 English
Appointment
Board/Management Information Classification · 100% confidence The document is an official communication addressed to stock exchanges regarding changes in the company's board of directors and key managerial personnel (KMP). It details re-designations and appointments of directors and KMP, referencing compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The content focuses on management changes rather than financial results, audit information, or other report types. There is no indication of financial data, earnings, or report publication. Therefore, this document fits the category of Board/Management Information (MANG). The document length and detail support a confident classification.
2020-02-03 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.